Decision-first laboratory reference
Peptide Analytical Methods Selection Matrix
Start with the question. Then choose the method. This source-linked matrix separates what seven common analytical approaches can support from what they cannot establish.
One result should answer one defined analytical question.
Chromatographic purity, molecular identity, sequence evidence, quantity, size variants, charge variants, and biological contamination are different attributes. A useful report identifies the sample, method, result, units, acceptance criteria, and limitations instead of asking one headline percentage to stand in for all of them.
Selection matrix
Match the method to the decision.
Each entry describes a typical use, not a universal validation claim. Actual support depends on the stated procedure, performance, reference materials, sample, and acceptance criteria.
Reversed-phase HPLC with UV detection
- Primary question
- How does the sample separate into UV-detected chromatographic components under the stated method?
- Typical output
- Chromatogram, retention times, integrated peak areas, and area percentages
- Can support
- A method-specific relative peak profile and chromatographic purity claim when integration rules and conditions are reported
- Does not establish
- Molecular identity, absolute peptide content, sequence, sterility, endotoxin status, or safety
Liquid chromatography–mass spectrometry
- Primary question
- Does mass-to-charge evidence associated with a separated component support the expected molecular mass?
- Typical output
- Chromatogram, mass spectrum, charge-state envelope, deconvoluted mass, and mass error
- Can support
- Molecular-mass and component-assignment evidence; quantitation only when a fit-for-purpose quantitative method is used
- Does not establish
- Complete sequence, positional isomer assignment, absolute content, sterility, endotoxin status, or safety by itself
LC-MS/MS or peptide mapping
- Primary question
- Do fragment or map features support the expected sequence or structural assignment?
- Typical output
- Fragment-ion spectrum, sequence coverage, identified fragments, or a comparative peptide map
- Can support
- Sequence-level or comparative structural evidence to the extent covered by the reported map and acceptance criteria
- Does not establish
- Unobserved sequence regions, absolute content, every impurity, sterility, endotoxin status, or biological activity
Amino-acid analysis
- Primary question
- Does measured amino-acid composition or calibrated content agree with the expected material?
- Typical output
- Residue composition, molar ratios, concentration, or total peptide/protein content
- Can support
- Composition evidence and, with suitable calibration and hydrolysis controls, quantitative content
- Does not establish
- Residue order, intact molecular mass, chromatographic purity, sterility, endotoxin status, or safety
Size-exclusion chromatography
- Primary question
- Are size-related species such as monomer, oligomer, aggregate, or fragment resolved under the stated conditions?
- Typical output
- Size-based chromatogram and relative peak areas
- Can support
- A method-specific profile of size-related species within the method's separation range
- Does not establish
- Exact molecular identity, sequence, absolute content, sterility, endotoxin status, or safety
Ion-exchange chromatography or capillary electrophoresis
- Primary question
- Does the sample contain separable charge-related variants under the stated pH and method conditions?
- Typical output
- Charge-variant chromatogram or electropherogram with migration or retention data
- Can support
- A method-specific charge-heterogeneity profile and comparison with a reference when one is used
- Does not establish
- Exact molecular identity, sequence, absolute content, sterility, endotoxin status, or safety
Separate microbiological, endotoxin, or sterility tests
- Primary question
- Was a defined biological-contamination attribute tested with an applicable method and acceptance criterion?
- Typical output
- Method-specific result, units, detection or quantitation limit, acceptance criterion, and disposition
- Can support
- Only the specific contamination attribute, sample, method, and lot actually tested
- Does not establish
- Peptide identity, chromatographic purity, sequence, content, overall safety, or the status of another lot
Interpretation workflow
Five checks before accepting an analytical claim.
- Write the exact decision the result must support.
- Confirm the sample identity, lot, matrix, preparation, and reference materials.
- Match the reported output and units to the claimed attribute.
- Review method performance and acceptance criteria for the intended use.
- Record every attribute the method did not test rather than treating it as implied.
Validation context
A named instrument is not a validated conclusion.
FDA's Q2(R2) guidance frames analytical validation around whether a procedure is fit for its intended purpose. Specificity, range, accuracy, precision, detection capability, robustness, and other performance characteristics matter in different combinations depending on the reportable result.
The matrix is therefore a question-selection aid, not a laboratory protocol. It does not prescribe sample preparation, instrument settings, acceptance criteria, or a release decision.
Sources
Primary guidance and analytical literature.
Analytical methods FAQ
Keep the conclusion inside the evidence.
Which test proves peptide purity?
No single method proves every meaning of purity. Reversed-phase HPLC can support a method-specific relative peak-area profile, while identity, content, sequence, water, residual materials, and biological contamination require separate evidence as applicable.
Can LC-MS identify a peptide?
LC-MS can provide strong molecular-mass and component-assignment evidence. The strength of an identity conclusion depends on the method, resolution, calibration, charge-state interpretation, reference material, acceptance criteria, and whether sequence-level evidence is also needed.
Does a 99% HPLC result mean 99% peptide by vial mass?
Not automatically. An HPLC area percentage is normally relative detector response from included integrated peaks under that method. It is not the same as absolute peptide content or mass balance unless the report uses and describes an applicable quantitative approach.
Do HPLC or LC-MS results establish sterility?
No. Sterility, microbial limits, and endotoxin are separate analytical questions that require their own applicable tests. C Suite Biologics products are shipped non-sterile.
How should a laboratory choose a peptide test?
Start with the exact decision the result must support, then define the analyte, sample matrix, expected range, reference materials, method performance, acceptance criteria, and limitations. Method validation or verification should be proportionate to the intended use.